P53 ALTERATIONS SHOW SIGNIFICANT CORRELATION WITH GENE AMPLIFICATION AND S-PHASE INDEX IN BREAST-CANCER

被引：0
|
作者：
CERVANTES, M
ZHOU, HY
SAHIN, A
DHINGRA, K
VALERO, V
ORDONEZ, N
ELNAGGAR, A
HESS, K
GLASSMAN, A
SEN, S
机构：
[1] UNIV TEXAS, MD ANDERSON CANC CTR, DIV LAB MED, HOUSTON, TX 77030 USA
[2] UNIV TEXAS, MD ANDERSON CANC CTR, DIV PATHOL, HOUSTON, TX 77030 USA
[3] UNIV TEXAS, MD ANDERSON CANC CTR, DEPT BREAST & GYNECOL MED ONCOL, HOUSTON, TX 77030 USA
[4] UNIV TEXAS, MD ANDERSON CANC CTR, DEPT BIOMATH, HOUSTON, TX 77030 USA
来源：
INTERNATIONAL JOURNAL OF ONCOLOGY | 1995年 / 6卷 / 05期
关键词：
P53; ONCOGENES; FLOW CYTOMETRY; BREAST CANCER;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Correlation of p53 gene/protein alterations with incidence of oncogene amplification, a potential marker of prognosis, was evaluated in 26 fresh breast cancer samples. p53 gene was analyzed by SSCP and DNA sequencing while p53 protein status was investigated by immunohistochemistry (IH). Amplification of c-erbB2/neu, c-myc, N-ras, int-2, hst, PRAD-1 and EGFR genes was studied by slot blot and in situ hybridizations. p53 alterations were found in 31% cases by SSCP and 42% by IH; gene amplification was detected in 27% cases. p53 gene alterations correlated significantly with gene amplification (p=0.006) and also with higher S-phase index (p=0.026), aneuploidy (p=0.026) and negative progesterone receptor status (p=0.043).
引用
收藏
页码：955 / 962
页数：8
相关论文
共 50 条
  • [41] Relationship between oncogene amplification, aneuploidy and altered expression of p53 in breast cancer
    Latham, C
    Maner, S
    Blegen, H
    Eriksson, E
    Zickert, P
    Auer, G
    Zetterberg, A
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1996, 8 (02) : 359 - 365
  • [42] AGNORS IN DUCTAL BREAST-CANCER - CORRELATION WITH PLOIDY AND S-PHASE FRACTION BY DNA FLOW-CYTOMETRY
    BORGIANI, L
    COGORNO, P
    OLIVIERO, J
    TOSO, F
    GAMBINI, G
    TUNESI, G
    CANEPA, M
    EUROPEAN JOURNAL OF HISTOCHEMISTRY, 1994, 38 (02): : 171 - 176
  • [43] Elevated transcription of the p53 gene in early S-phase leads to a rapid DNA-damage response during S-phase of the cell cycle
    Paula Takahashi
    Amanda Polson
    David Reisman
    Apoptosis, 2011, 16 : 950 - 958
  • [44] P53 AND CATHEPSIN-D ARE INDEPENDENT OF ESTABLISHED PROGNOSTIC FACTORS IN BREAST-CANCER
    SILVESTRINI, R
    VENERONI, S
    BENINI, E
    DIFRONZO, G
    DAIDONE, MG
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1992, 1 (05) : 507 - 512
  • [45] A NOVEL P53 MUTANT IN HUMAN BREAST-CANCER REVEALED BY MULTIPLE SSCP ANALYSIS
    NIGRO, V
    NAPOLITANO, M
    ABBONDANZA, C
    MEDICI, N
    PUCA, AA
    SCHIAVULLI, M
    ARMETTA, I
    MONCHARMONT, B
    PUCA, GA
    MOLINARI, AM
    CANCER LETTERS, 1994, 79 (01) : 73 - 75
  • [46] Serum p53 antibodies in correlation to other biological parameters of breast cancer
    Sangrajrang, S
    Arpornwirat, W
    Cheirsilpa, A
    Thisuphakorn, P
    Kalalak, A
    Sornprom, A
    Soussi, T
    CANCER DETECTION AND PREVENTION, 2003, 27 (03): : 182 - 186
  • [47] REGULATION OF P53 PROTEIN EXPRESSION IN HUMAN BREAST-CANCER CELL-LINES
    VOJTESEK, B
    LANE, DP
    JOURNAL OF CELL SCIENCE, 1993, 105 : 607 - 612
  • [48] Loss of hMSH2 expression in primary breast cancer with p53 alterations
    Spagnoletti, I
    Pizzi, C
    Galietta, A
    Di Maio, M
    Mastranzo, P
    Daniele, S
    Limite, G
    Pettinato, G
    Contegiacomo, A
    ONCOLOGY REPORTS, 2004, 11 (04) : 845 - 851
  • [49] P53 GENE-MUTATIONS AND STEROID-RECEPTOR STATUS IN BREAST-CANCER - CLINICOPATHOLOGICAL CORRELATIONS AND PROGNOSTIC ASSESSMENT
    CALEFFI, M
    TEAGUE, MW
    JENSEN, RA
    VNENCAKJONES, CL
    DUPONT, WD
    PARL, FF
    CANCER, 1994, 73 (08) : 2147 - 2156
  • [50] NUCLEAR P53 IMMUNOREACTION ASSOCIATED WITH POOR PROGNOSIS OF BREAST-CANCER
    IWAYA, K
    TSUDA, H
    HIRAIDE, H
    TAMAKI, K
    TAMAKUMA, S
    FUKUTOMI, T
    MUKAI, K
    HIROHASHI, S
    JAPANESE JOURNAL OF CANCER RESEARCH, 1991, 82 (07): : 835 - 840
12345